Condition
Acute Undifferentiated Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Acute Undifferentiated Leukemia clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Australia (1)). By phase: Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Acute Undifferentiated Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Decitabine plus FLAG‑Ida chemotherapy and total‑body irradiation before donor stem cell transplant for adults with high‑risk myeloid cancers | Phase 1/2 | Seattle, Washington | Recruiting | Apr 15, 2025 |
| Using Tagraxofusp to treat pediatric patients with relapsed or refractory blood cancers | Phase 1 | Los Angeles, California and 30 other locations | Recruiting | Jul 27, 2022 |
| Engineered donor graft for pediatric blood cancer treatment | Phase 1/2 | Gainesville, Florida and 3 other locations | Recruiting | Apr 12, 2022 |
| HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant | Phase 1 | Seattle, Washington | Recruiting | Oct 31, 2017 |
All recruiting trials (4)
-
Decitabine plus FLAG‑Ida chemotherapy and total‑body irradiation before donor stem cell transplant for adults with high‑risk myeloid cancers
This test tries whether adding decitabine to FLAG‑Ida chemotherapy and total‑body irradiation before a donor stem cell transplant helps adults with high‑risk or relapsed myeloid blood cancers live longer and stay in remission.
-
Using Tagraxofusp to treat pediatric patients with relapsed or refractory blood cancers
This study is testing a new drug called Tagraxofusp to see if it can help children and young adults with tough-to-treat blood cancers feel better and improve their chances of recovery.
-
Engineered donor graft for pediatric blood cancer treatment
This study is testing a new type of donor graft called Orca-Q to see if it can help children with blood cancers do better after a stem cell transplant.
-
HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant
This Phase 1 study will test whether giving specially engineered donor T cells called HA-1 TCR T cells is safe and what dose works for people whose acute leukemia came back or didn't respond after a donor stem cell transplant.
Related topics
Quick answers
How many Acute Undifferentiated Leukemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.